Stock Chart

PYXS

$2.19 -6.01%
Score: 35.9 AVOID NEW MONEY
Pro
Screener
Vol: 2.00x (vs SPY: 1.9x | vs QQQ: 1.8x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Oct 01, 2026
No qualifying chart pattern in the trailing 60 sessions — we only flag setups that pass our quality gate.
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About PYXS - Pyxis Oncology, Inc. Common Stock

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.

Key Statistics

Market Cap $194M

This PYXS stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track PYXS's price movements with trendlines, gamma walls, and key support/resistance levels.